Biotechnology/Chemical/Pharmaceutical Customer Partnership- March 16, 2017

The United States Patent and Trademark Office Biotechnology, Chemical and Pharmaceutical (BCP)
Partnership Meeting


Thursday, March 16, 2017

10:00am to 5:00pm (EDT)


We are pleased to announce the USPTO’s next Biotechnology, Chemical and Pharmaceutical Customer Partnership (BCP) Meeting. This BCP meeting expands our long-standing partnership in these industry sectors to customers across the country. The next BCP Meeting will be held on March 16, 2017 in the USPTO Headquarters (Alexandria, VA) as well as available for online participation. This partnership meeting is designed to provide an informal conduit for all stakeholders to share insights and experiences to improve patent prosecution in biotechnology areas. We highly value our customers’ feedback and input, and the individual participation is important in our efforts to continuously improve the quality of our products and services.


Please see below for Registration information on how you can participate.


Date and Location:  The Partnership Meeting will be held on March 16th (Thursday) from 10:00am – 5:00pm at Alexandria, VA.

From the Agenda, for full agenda see



10:10 – 11:10am



Rationale Statements in 35 U.S.C. 103



Cassandra Spyrou,   Supervisory Review Quality Assurance Specialist, OPQA, USPTO



11:10am – 12:00pm



The Role of   Inherency in Making an Obviousness Determination



William Smith, Of Counsel, BakerHostetler



1:00 – 1:40pm (EDT)



37 CFR §1.132 Practice, Unexpected Results



Scarlett Goon, QAS, TC1600, USPTO



1:40 – 2:40pm (EDT)



Range Analysis



Jean Witz, SPE, CRU, USPTO



Registration Information


Please email USPTOBCP1600@USPTO.GOV (link sends e-mail) to RSVP by March, 13th. Please include “BCP RSVP” in the email subject line.  In the email body, please include the following information:

  • Your name, title and organization

  • Contact information (e-mail, phone, etc.)

  • Your attending location (In Person or online).


Note: the event would not be recorded (ab)


  • No labels